Weekly Digest – 01-07 Aug 2023 Weekly Digest – 01-07 Aug 2023 02 Aug 2023: LONSURF (trifluridine/tipiracil) / Bevacizumab / mCRC / Taiho Oncology: Approved in the US Based on the results from the Phase 3 SUNLIGHT study, LONSURF received […]
Weekly Digest – 01-07 Aug 2023 Weekly Digest – 01-07 Aug 2023 01 Aug 2023: Elraglusib / Pancreatic Cancer / Acutate Therapeutics: Orphan Drug Designation by the FDA (ODD) Elraglusib is Actuate’s proprietary small molecule glycogen synthase kinase-3 beta (GSK-3β) […]
Weekly Digest – 01-07 Aug 2023 Weekly Digest – 01-07 Aug 2023 01 Aug 2023: Vanquish Minimally Invasive Prostate Cancer Therapy: Breakthrough Device Designation by the FDA Vanquish water vapor technology applies the thermal energy stored in a few drops […]
